4.5 Review

Looking for novel ways to treat the hallmarks of Alzheimer's disease

Journal

EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 16, Issue 8, Pages 1183-1196

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1517/13543784.16.8.1183

Keywords

beta-amyloid; Alzheimer's disease; cholinergic; dementia; microtubules; mild cognitive; impairment; secretase; tau; therapeutics; tubulin

Ask authors/readers for more resources

Alzheimer's disease (AD) represents an increasing public health issue as demographic changes and generally improved medical care result in a larger aged population. Although significant advances have been made in the diagnosis and treatment of AD, the unmet medical need remains and few treatment options are available. This review focuses on emerging therapies that aim to treat the underlying causes of the disease rather than the symptoms. Such disease-modifying treatments, focused on the two main hallmarks of the disease (plaques and tangles), include new and old targets which have significant potential in the field and are on the cusp of providing new treatment paradigms within the coming years.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available